Cited by 79Malaria Research and ControlPhytochemical compounds biological activitiesEthnobotanical and Medicinal Plants Studies

Artemisia annua dried leaf tablets treated malaria resistant to ACT and i.v. artesunate: Case reports

Open access
Daddy, Nsengiyumva Bati, Kalisya, Luc Malemo, Bagire, Pascal Gisenya, Watt, Robert L., Towler, Melissa J., Weathers, Pamela J.·2017·Phytomedicine

Abstract

Background Dried leaf Artemisia annua (DLA) has shown efficacy against Plasmodium sp. in rodent studies and in small clinical trials. Rodent malaria also showed resiliency against the evolution of artemisinin drug resistance.Purpose This is a case report of a last resort treatment of patients with severe malaria who were responding neither to artemisinin combination therapy (ACT) nor i.v. artesunate.Study design Of many patients treated with ACTs and i.v. artesunate during the 6 mon study period, 18 did not respond and were subsequently treated with DLA Artemisia annua.Methods Patients were given a dose of 0.5g DLA per os, twice daily for 5d. Total adult delivered dose of artemisinin was 55mg. Dose was reduced for body weight under 30kg. Clinical symptoms, e.g. fever, coma etc., and parasite levels in thick blood smears were tracked. Patients were declared cured and released from hospital when parasites were microscopically undetectable and clinical symptoms fully subsided.Results All patients were previously treated with Coartem® provided through Santé Rurale (SANRU) and following the regimen prescribed by WHO. Of 18 ACT-resistant severe malaria cases compassionately treated with DLA, all fully recovered. Of the 18, this report details two pediatric cases.Conclusions Successful treatment of all 18 ACT-resistant cases suggests that DLA should be rapidly incorporated into the antimalarial regimen for Africa and possibly wherever else ACT resistance has emerged.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phymed.2017.04.006

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dry leaf consumption seems resilient against the evolution of artemisinin drug resistance as shown in humans and in Plasmodium yoelii-infected mice.

    “Another reason for increasing the in planta artemisinin content is that dry leaf consumption of A. annua is showing efficacy in human trials (Daddy et al. 2017; Munyangi et al. 2019) and seems resilient against the evolution of artemisinin drug resistance as maybe shown in humans (Daddy et al. 2017) and in Plasmodium yoelii -infected mice (Elfawal et al. 2015).”

    From Enhancing artemisinin content in and delivery from Artemisia annua: a review of alternative, classical, and transgenic approaches (2021) · cites this paper as Daddy et al. 2017

    The Conclusions report that dried-leaf Artemisia annua controlled 18 ACT-resistant malaria cases in humans. That supports possible efficacy against existing resistance, but the case reports do not establish that dry-leaf consumption slows the evolution of resistance in humans. The paper's Background attributes reduced emergence of resistance to rodent work; the citing sentence separately cites Elfawal et al. for the mice. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Dry leaf consumption of A. annua is showing efficacy in human trials.

    “Another reason for increasing the in planta artemisinin content is that dry leaf consumption of A. annua is showing efficacy in human trials (Daddy et al. 2017; Munyangi et al. 2019) and seems resilient against the evolution of artemisinin drug resistance as maybe shown in humans (Daddy et al. 2017) and in Plasmodium yoelii -infected mice (Elfawal et al. 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Daddy, N. B., Kalisya, L. M., Bagire, P. G., Watt, R. L., Towler, M. J., & Weathers, P. J.
Affiliations
  • Plexision (United States) (US)
  • Worcester Polytechnic Institute (US)
Corresponding author
Weathers, Pamela J.
Venue
Phytomedicine
Publisher
Elsevier BV
Published
2017-08
Volume
32
Pages
37-40
ISSN
0944-7113 (ISSN-L)
OpenAlex
W2606166051
Cited by
79
References
19
Citations by year
2026: 2 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 14 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 3
FWCI
8.97
Type
journal article
Language
en
Open access
Locations
  • Phytomedicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Center for Complementary and Integrative Health (R15AT008277)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical compounds biological activities
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Ethnobotanical and Medicinal Plants Studies
Keywords
Artemisia annua, artemisinin resistance, artemisinin-based combination therapy, artesunate, severe malaria, Plasmodium, last-resort treatment, pediatric malaria, antimalarial drug resistance, artemether-lumefantrine
MeSH terms
Artesunate, Artemether, Lumefantrine Drug Combination, Adolescent, Adult, Antimalarials, Child, Child, Preschool, Drug Combinations, Drug Resistance, Microbial, Ethanolamines, Female, Fluorenes, Humans, Infant, Malaria, Male, Middle Aged, Tablets, Treatment Outcome, Plant Leaves, Artemisia annua, Artemisinins, Young Adult, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review